DSG2 and neoplasm: DSG2 has been associated with a poor prognosis and increased recurrence risk in breast cancer patients and is linked to an increased metastatic potential of breast cancer cells by promoting cell clustering and enhancing cell survival during tumor cell dissemination [56].